Pfizer Inc - NAI
FDA Inspections Database
Pfizer Inc - NAI
FDA Inspections Database
U.S. FDA inspection classifications and citation records from the official FDA inspection database.
- Total Records 12
- Latest Inspection 2023-09-12
- Data Source U.S. FDA
- Last Updated 2024-01-31
Company Overview
Social Profiles
Company Snapshot
FDA Inspections Timeline (12 records)
Legal Name
PF Prism CV
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2023-09-12
FMD Date
2024-01-31
Fiscal Year
2023
State
California
Additional Details
Sponsor, Contract Research Organization
Location
San Diego, California, United States
Inspection Info
Fiscal Year: 2023
Citations: No
Legal Name
Pfizer Inc
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2019-08-20
FMD Date
2019-09-11
Fiscal Year
2019
State
Missouri
Location
Chesterfield, Missouri, United States
Inspection Info
Fiscal Year: 2019
Citations: No
Legal Name
Pfizer Inc
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2017-09-08
FMD Date
2019-06-19
Fiscal Year
2017
State
New Jersey
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Peapack, New Jersey, United States
Inspection Info
Fiscal Year: 2017
Citations: No
Legal Name
PF Prism CV
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2014-09-05
FMD Date
-
Fiscal Year
2014
State
Connecticut
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Groton, Connecticut, United States
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
Pfizer Inc
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2014-05-21
FMD Date
-
Fiscal Year
2014
State
Missouri
Location
Chesterfield, Missouri, United States
Inspection Info
Fiscal Year: 2014
Citations: No
Legal Name
Pfizer Inc
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2012-02-29
FMD Date
-
Fiscal Year
2012
State
Missouri
Location
Chesterfield, Missouri, United States
Inspection Info
Fiscal Year: 2012
Citations: No
Legal Name
Pfizer Inc
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2011-08-25
FMD Date
-
Fiscal Year
2011
State
North Carolina
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)
Location
Cary, North Carolina, United States
Inspection Info
Fiscal Year: 2011
Citations: No
Legal Name
Pfizer Inc
Project Area
Bioresearch Monitoring
Product Type
Drugs
Posted Citations
No
Inspection End Date
2010-08-26
FMD Date
-
Fiscal Year
2010
State
North Carolina
Additional Details
Postmarket Adverse Drug Experience (PADE)
Location
Cary, North Carolina, United States
Inspection Info
Fiscal Year: 2010
Citations: No
Legal Name
Pfizer Inc
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2010-06-24
FMD Date
-
Fiscal Year
2010
State
Indiana
Location
Terre Haute, Indiana, United States
Inspection Info
Fiscal Year: 2010
Citations: No
Legal Name
Pfizer Inc
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Product Type
Veterinary
Posted Citations
No
Inspection End Date
2010-06-24
FMD Date
-
Fiscal Year
2010
State
Indiana
Location
Terre Haute, Indiana, United States
Inspection Info
Fiscal Year: 2010
Citations: No
Legal Name
Pfizer Inc
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2009-07-23
FMD Date
-
Fiscal Year
2009
State
Indiana
Location
Terre Haute, Indiana, United States
Inspection Info
Fiscal Year: 2009
Citations: No
Legal Name
Pfizer Pharmaceuticals LLC
Project Area
Drug Quality Assurance
Product Type
Drugs
Posted Citations
No
Inspection End Date
2009-01-13
FMD Date
-
Fiscal Year
2009
State
Puerto Rico
Location
Arecibo, Puerto Rico, United States
Inspection Info
Fiscal Year: 2009
Citations: No
Classification Breakdown
12 total- NAI (No Action Indicated)
Official Source
All data is sourced from the official FDA inspection database maintained by the U.S. Food and Drug Administration.
Visit FDA.govRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Location
San Diego, California, United States
Inspection Info
Fiscal Year: 2023
Citations: No
100% Official Data
Directly from the U.S. FDA inspection database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.